Metabolic Regulation and Obesity
Prevention and Control
Category(ies) of Research
Descriptor of Research
My research efforts are focused on the association of genetic variation with clinical outcomes in patients with cardiovascular disease and on the role of genetic variation in the variable response to pharmacologic treatment (i.e. Pharmacogenomics) of cardiovascular disease. I have a specific interest in patients with both diabetes mellitus and coronary artery disease. The ultimate goal of my research is to personalize each patient’s treatment based on their genotype. I am the PI or an active investigator on several NIH-sponsored studies, a collaborator on the NHLBI-sponsored Exome Sequencing Program (ESP) Myocardial Infarction (MI) Project Team, and am the Director of Director of the Applied Genomics Core Laboratory for the TRIUMPH (Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients’ Health status) cohort.